Johannesburg Declaration, A civil society declaration to UN Secretary- General High Level Panel on Access to Medicines highlights the factors that interlink system of financing biodmedical research, innovation and access to health technologies. It denounces the research funding that relies upon the grant of monopolies which eventually ‘produces to innovation gaps, inefficiencies, and distortions in the development of new health technologies’. The declaration clearly recommends ‘the costs of medical research and development should be delinked from the price of health technologies.’
- U.S. wants patent form recall
- Will the Trump tariffs on China raise drug prices for Americans?
- Dutch hospital challenges big pharma by making own version of very pricey drug
- India’s ailing battle against TB: One in five multidrug-resistant patients do not complete treatment
- Why do new medicines cost so much, and what can we do about it?